Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


Articles published in Arch Pathol Lab Med

Retrieve available abstracts of 41 articles:
HTML format



Single Articles


    February 2021
  1. TERRA SBSP, Roden AC, Aubry MC, Yi ESJ, et al
    Utility of Immunohistochemistry for MUC4 and GATA3 to Aid in the Distinction of Pleural Sarcomatoid Mesothelioma From Pulmonary Sarcomatoid Carcinoma.
    Arch Pathol Lab Med. 2021;145:208-213.
    PubMed     Abstract available


    January 2021
  2. NAMBIRAJAN A, Singh V, Bhardwaj N, Mittal S, et al
    SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature.
    Arch Pathol Lab Med. 2021;145:90-98.
    PubMed     Abstract available


    September 2020
  3. STAAF J, Tran L, Soderlund L, Nodin B, et al
    Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers.
    Arch Pathol Lab Med. 2020;144:1075-1085.
    PubMed     Abstract available


    June 2020
  4. HUANG RSP, Smith D, Le CH, Liu WW, et al
    Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization.
    Arch Pathol Lab Med. 2020;144:735-741.
    PubMed     Abstract available


    May 2020
  5. IBRAHIM A, Chopra S
    Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors.
    Arch Pathol Lab Med. 2020;144:655-660.
    PubMed     Abstract available


    April 2020
  6. REKHTMAN N
    "Napoleon Hat" Sign: A Distinctive Cytologic Clue to Reactive Pneumocytes.
    Arch Pathol Lab Med. 2020;144:443-445.
    PubMed     Abstract available


  7. LE STANG N, Burke L, Blaizot G, Gibbs AR, et al
    Differential Diagnosis of Epithelioid Malignant Mesothelioma With Lung and Breast Pleural Metastasis: A Systematic Review Compared With a Standardized Panel of Antibodies-A New Proposal That May Influence Pathologic Practice.
    Arch Pathol Lab Med. 2020;144:446-456.
    PubMed     Abstract available


    March 2020
  8. PARRA ER, Jiang M, Machado-Rugolo J, Yaegashi LB, et al
    Variants in Epithelial-Mesenchymal Transition and Immune Checkpoint Genes Are Associated With Immune Cell Profiles and Predict Survival in Non-Small Cell Lung Cancer.
    Arch Pathol Lab Med. 2020 Mar 9. doi: 10.5858/arpa.2019-0419.
    PubMed     Abstract available


  9. COZZOLINO I, Ronchi A, Messina G, Montella M, et al
    Adequacy of Cytologic Samples by Ultrasound-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology of Peripheral Pulmonary Nodules for Morphologic Diagnosis and Molecular Evaluations: Comparison With Computed Tomography-Guided Percutaneous
    Arch Pathol Lab Med. 2020;144:361-369.
    PubMed     Abstract available


    February 2020
  10. DERAKHSHAN F, Ionescu D, Cheung S, Churg A, et al
    Use of Programmed Death Ligand-1 (PD-L1) Staining to Separate Sarcomatoid Malignant Mesotheliomas From Benign Mesothelial Reactions.
    Arch Pathol Lab Med. 2020;144:185-188.
    PubMed     Abstract available


    January 2020
  11. NIZAMADDIN SK, Mehrotra M, Nadhim ASH, Luthra R, et al
    Detection of EGFR T790M Mutation by Droplet Digital Polymerase Chain Reaction in Lung Carcinoma Cytology Samples.
    Arch Pathol Lab Med. 2020 Jan 6. doi: 10.5858/arpa.2019-0411.
    PubMed     Abstract available


    May 2019
  12. LAYFIELD LJ, Hammer RD, White SK, Furtado LV, et al
    Molecular Testing Strategies for Pulmonary Adenocarcinoma: An Optimal Approach With Cost Analysis.
    Arch Pathol Lab Med. 2019;143:628-633.
    PubMed     Abstract available


    April 2019
  13. HUANG RSP, Holmes BF, Powell C, Marati RV, et al
    Delta-like Protein 3 Prevalence in Small Cell Lung Cancer and DLL3 (SP347) Assay Characteristics.
    Arch Pathol Lab Med. 2019 Apr 8. doi: 10.5858/arpa.2018-0497.
    PubMed     Abstract available


    January 2019
  14. LU YW, Yeh YC
    Ciliated Muconodular Papillary Tumors of the Lung.
    Arch Pathol Lab Med. 2019;143:135-139.
    PubMed     Abstract available


    December 2018
  15. LAMBROS L, Uguen A
    NanoString System Versus Multiplex Fluorescent In Situ Hybridization for Gene Fusion Diagnosis in Lung Cancer Cytology Samples: Competing or Complementary Methods?
    Arch Pathol Lab Med. 2018;142:1451-1452.
    PubMed    


    November 2018
  16. TROSCHEL FM, Gottumukkala RV, DiCorpo D, Mario J, et al
    Feasibility of Perioperative Micro-Computed Tomography of Human Lung Cancer Specimens: A Pilot Study.
    Arch Pathol Lab Med. 2018 Nov 20. doi: 10.5858/arpa.2018-0249.
    PubMed     Abstract available


    October 2018
  17. THUNNISSEN E
    How to Validate Predictive Immunohistochemistry Testing in Pathology?: A Practical Approach Exploiting the Heterogeneity of Programmed Death Ligand-1 Present in Non-Small Cell Lung Cancer.
    Arch Pathol Lab Med. 2018 Oct 11. doi: 10.5858/arpa.2018-0410.
    PubMed    


    August 2018
  18. AKALIN A, Ergin A, Remiszewski S, Mu X, et al
    Resolving Interobserver Discrepancies in Lung Cancer Diagnoses by Spectral Histopathology.
    Arch Pathol Lab Med. 2018 Aug 24. doi: 10.5858/arpa.2017-0476.
    PubMed     Abstract available


  19. BORCZUK AC
    Uncommon Types of Lung Carcinoma With Mixed Histology: Sarcomatoid Carcinoma, Adenosquamous Carcinoma, and Mucoepidermoid Carcinoma.
    Arch Pathol Lab Med. 2018;142:914-921.
    PubMed     Abstract available


    July 2018
  20. BORCZUK AC
    Keeping Up With Testing Guidelines in Lung Cancer.
    Arch Pathol Lab Med. 2018;142:783-784.
    PubMed    


    June 2018
  21. LUK PP, Selinger CI, Mahar A, Cooper WA, et al
    Biomarkers for ALK and ROS1 in Lung Cancer: Immunohistochemistry and Fluorescent In Situ Hybridization.
    Arch Pathol Lab Med. 2018 Jun 14. doi: 10.5858/arpa.2017-0502.
    PubMed     Abstract available


    April 2018
  22. SAXENA A
    Molecular Testing for Stage IV Non-Small Cell Lung Cancer Patients with Targetable Mutations Following Disease Progression.
    Arch Pathol Lab Med. 2018 Apr 12. doi: 10.5858/arpa.2018-0111.
    PubMed    


  23. PLANCHARD D, Johnson BE
    BRAF Adds an Additional Piece of the Puzzle to Precision Oncology-Based Treatment Strategies in Lung Cancer.
    Arch Pathol Lab Med. 2018 Apr 12. doi: 10.5858/arpa.2018-0088.
    PubMed    


  24. HALMOS B
    Molecular Testing in Lung Cancer: Where to Draw the Line?
    Arch Pathol Lab Med. 2018 Apr 6. doi: 10.5858/arpa.2018-0060.
    PubMed    


  25. ALTORKI NK
    Molecular Testing for Early Lung Cancer.
    Arch Pathol Lab Med. 2018 Apr 6. doi: 10.5858/arpa.2018-0087.
    PubMed    


  26. GUERINI-ROCCO E, Passaro A, Casadio C, De Luca VM, et al
    Acquired Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers: The Role of Next-Generation Sequencing on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples.
    Arch Pathol Lab Med. 2018;142:465-473.
    PubMed     Abstract available


  27. ALI G, Bruno R, Savino M, Giannini R, et al
    Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?
    Arch Pathol Lab Med. 2018;142:480-489.
    PubMed     Abstract available


    March 2018
  28. AISNER DL
    The Revised College of American Pathologists/International Association for the Study of Lung Cancer Guidelines/Association for Molecular Pathology: A Step Forward for Molecular Cytopathology.
    Arch Pathol Lab Med. 2018 Mar 29. doi: 10.5858/arpa.2018-0081.
    PubMed    


  29. JAIN D, Roy-Chowdhuri S
    Molecular Pathology of Lung Cancer Cytology Specimens: A Concise Review.
    Arch Pathol Lab Med. 2018 Mar 16. doi: 10.5858/arpa.2017-0444.
    PubMed     Abstract available


  30. LOZANO MD, Echeveste JI, Abengozar M, Mejias LD, et al
    Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer: Doing More With Less.
    Arch Pathol Lab Med. 2018;142:291-298.
    PubMed     Abstract available


    February 2018
  31. DEL C MONROIG-BOSQUE P, Driver B, Morales-Rosado JA, Deavers M, et al
    Correlation Between Programmed Death Receptor-1 Expression in Tumor-Infiltrating Lymphocytes and Programmed Death Ligand-1 Expression in Non-Small Cell Lung Carcinoma.
    Arch Pathol Lab Med. 2018 Feb 12. doi: 10.5858/arpa.2017-0516.
    PubMed     Abstract available


    January 2018
  32. DOXTADER EE, Cheng YW, Zhang Y
    Molecular Testing of Non-Small Cell Lung Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Fine-Needle Aspiration.
    Arch Pathol Lab Med. 2018 Jan 26. doi: 10.5858/arpa.2017-0184.
    PubMed     Abstract available


  33. LINDEMAN NI, Cagle PT, Aisner DL, Arcila ME, et al
    Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and
    Arch Pathol Lab Med. 2018 Jan 22. doi: 10.5858/arpa.2017-0388.
    PubMed     Abstract available


  34. WALTS AE, Marchevsky AM
    Current Evidence Does Not Warrant Frozen Section Evaluation for the Presence of Tumor Spread Through Alveolar Spaces.
    Arch Pathol Lab Med. 2018;142:59-63.
    PubMed     Abstract available


  35. HUSAIN AN, Colby TV, Ordonez NG, Allen TC, et al
    Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
    Arch Pathol Lab Med. 2018;142:89-108.
    PubMed     Abstract available


    December 2017
  36. MEHRAD M, Roy S, Bittar HT, Dacic S, et al
    Next-Generation Sequencing Approach to Non-Small Cell Lung Carcinoma Yields More Actionable Alterations.
    Arch Pathol Lab Med. 2017 Dec 8. doi: 10.5858/arpa.2017-0046.
    PubMed     Abstract available


    November 2017
  37. DRIVER BR, Miller RA, Miller T, Deavers M, et al
    Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.
    Arch Pathol Lab Med. 2017;141:1529-1532.
    PubMed     Abstract available


    September 2017
  38. WOO JS, Reddy OL, Koo M, Xiong Y, et al
    Application of Immunohistochemistry in the Diagnosis of Pulmonary and Pleural Neoplasms.
    Arch Pathol Lab Med. 2017;141:1195-1213.
    PubMed     Abstract available


    August 2017
  39. PENG Y, Butt YM, Chen B, Zhang X, et al
    Update on Immunohistochemical Analysis in Breast Lesions.
    Arch Pathol Lab Med. 2017;141:1033-1051.
    PubMed     Abstract available


    July 2017
  40. WANG X, Gao Y, Wang B, Zhang Z, et al
    Analytic and Clinical Validation of an Ultrasensitive, Quantitative Polymerase Chain Reaction Assay for EGFR Mutation Analysis With Circulating Tumor DNA.
    Arch Pathol Lab Med. 2017;141:978-984.
    PubMed     Abstract available


    June 2017
  41. JAIN D, Allen TC, Aisner DL, Beasley MB, et al
    Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.
    Arch Pathol Lab Med. 2017 Jun 22. doi: 10.5858/arpa.2017-0114.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: